Sign up
Healthed-White-on-Blue

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong

Weight Management in Women of Reproductive Age

Jarrod Warner & Irene Schneider

Jarrod Warner & Irene Schneider

New Spirometry Standards: Key Changes for Clinical Practice

A/Prof Alberto Pinzon Charry

A/Prof Alberto Pinzon Charry

Food Allergy Prevention

A/Prof Daryl Cheng

A/Prof Daryl Cheng

Protecting Young Lungs – Paediatric Insights into RSV

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

23 June 2026
Register Now
Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent's Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University

Date published: 24 October 2023

Discover

Healthed

CPD platform